On Dec. 28, 2021, Dynavax announced that Biological E had reported that CORBEVAXﾙ, their COVID-19 vaccine which contains Dynavax’s CpG 1018ﾮ adjuvant, received approval for emergency use from the Drugs Controller General of India (DCGI).

Dynavax and Biological E previously announced the execution of a commercial supply agreement (CSA) for Dynavax to supply its CpG 1018 adjuvant for use in Biological E’s CORBEVAX.